ArticleCase reports in oncology

Pathologically Complete Response to Camrelizumab and Apatinib in Advanced Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report.

Zhi-Ping Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.